[Study of the antitoxic function of the liver using 131I-sodium benzoate in esophageal cancer].
The use of 131I-sodium benzoate made it possible to establish disorder of antitoxic hepatic function in 60% of patients with esophageal cancer as well as differences of this function depending on the level of tumor site in the esophagus. The initial state of antitoxic hepatic function has been shown to produce a certain effect on direct results of chemoradio- and radiotherapy of patients with esophageal cancer.
D000328:Adult; D000368:Aged; D001565:Benzoates; D019817:Benzoic Acid; D003131:Combined Modality Therapy; D004938:Esophageal Neoplasms / Q000188:drug therapy / Q000503:physiopathology* / Q000532:radiotherapy; D005260:Female; D006801:Humans; D007457:Iodine Radioisotopes; D008099:Liver / Q000503:physiopathology*; D008297:Male; D008875:Middle Aged
D001565:Benzoates; D007457:Iodine Radioisotopes; D019817:Benzoic Acid
Issledovanie antitoksicheskoĭ funktsii pecheni s 131I-natriem benzoatom u bol'nykh rakom pishchevoda.